Open AccessParotid salivary parameters in bulimic patients – a controlled clinical trial.
Author(s) -
Elżbieta Paszyńska,
Agnieszka Słopień,
Monika Węglarz,
R.W.A. Linden
Publication year - 2015
Publication title -
psychiatria polska
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.414
H-Index - 22
eISSN - 2391-5854
pISSN - 0033-2674
DOI - 10.12740/pp/31267
Subject(s) - medicine , clinical trial , dermatology
The aim of this study was to determine whether patients with purging-type bulimia and/or non-bulimic patients, treated with serotonin reuptake inhibitor SI-5-HT (fluoxetine), have dental erosion and changes in selected buffer components of parotid saliva (bicarbonates, phosphates, urea), compared with the healthy population.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom